Latest news
Loading news…
Biodexa Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Abingdon, Oxfordshire, United Kingdom Founded 2000 11-50 employees For Profit
Biodexa Pharmaceuticals is a pharmaceutical company focused on particle engineering with an emphasis on microfluidics and drug delivery.
Biodexa Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$99.12M
Funding Rounds
10
Last Funding
Acquisitions
2
Monthly Visits
Contacts
11
Ticker
MTPH
LSE - London Stock Exchange
Patents
0
3 trademarks
About Biodexa Pharmaceuticals
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- MTPH
- Exchange
- LSE - London Stock Exchange
- IPO date
- Dec 19, 2014
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 25
- Patents granted
- 0
- Trademarks
- 3
- IT spend
- $8.26K
Company Info
- Founded
- 2000
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 145
- HQ
- Abingdon, Oxfordshire, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Dec 19, 2014
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.5
- Trend (30d)
- 6.9
- Trend (90d)
- 4.3
- Last leadership hire
- Jan 5, 2026
Biodexa Pharmaceuticals Funding Rounds
10 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 10Show
Page 1 / 2
Biodexa Pharmaceuticals Acquisitions
2 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| DARA BioSciences | $30.77M | 2015-06-04 | Biodexa Pharmaceuticals | BiotechnologyDeveloper PlatformOncologyPharmaceutical | United States |
| Q Chip | — | 2014-12-12 | Biodexa Pharmaceuticals | BiotechnologyLife ScienceTherapeutics | United Kingdom |
1–2 of 2Show
Page 1 / 1
Biodexa Pharmaceuticals Key People
Non-Executive Director & Member Remuneration and Audit Committees
Head GNP Design & Manufacture
Chief Financial Officer and Company Secretary
Non-Executive Director & Member Audit Committee
Board of Directors
Chief Scientific Officer
Chief Executive Officer
11
professional contacts at Biodexa Pharmaceuticals
Contact execs at Biodexa Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Biodexa Pharmaceuticals
Loading news…
FAQs about Biodexa Pharmaceuticals
People who checked this page also checked these
Sectors Biodexa Pharmaceuticals invests & acquires in
Browse the full Acquirezy directory.